Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Cross-sectional Analysis of T Cell Responses to Synthetic Peptide Immuno-Regulatory Epitopes (SPIREs) for Multiple Allergens in Subjects With Allergy in North America

NCT02601690 is registered in ClinicalTrials.gov with Adiga Life Sciences, Inc. as lead sponsor.

NCT NCT02601690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Cross-sectional Analysis of T Cell Responses to Synthetic Peptide Immuno-Regulatory Epitopes (SPIREs) for Multiple Allergens in Subjects With Allergy in North America
Lead sponsor
Adiga Life Sciences, Inc.
Phase
Observational
Overall status
Terminated
Start date
October 31, 2015
Completion date
June 25, 2017
Enrollment
199 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergy